Stocks · Korea
019170
KOSPI
Shinpoong Pharmaceutical
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
Returns and 52-week range
1W+21.93%
1M+9.01%
3M+35.26%
6M+1.01%
1Y-22.79%
YTD-21.02%
52W high15,900원
52W low6,310원
From 52W high-30.75%
Financial results (consolidated)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2022 | 2,093억 | -340억 | -353억 | -16.2% |
| 2023 | 2,002억 | -474억 | -573억 | -23.7% |
| 2024 | 2,211억 | -205억 | -154억 | -9.2% |
| 2025 | 2,347억 | 143억 | 84억 | 6.1% |
| Quarterly | ||||
| 2024 4Q | 553억 | -121억 | -127억 | -21.9% |
| 2025 1Q | 554억 | -18억 | -13억 | -3.2% |
| 2025 2Q | 586억 | 49억 | 28억 | 8.4% |
| 2025 3Q | 626억 | 72억 | 64억 | 11.5% |
| 2025 4Q | 580억 | 39억 | 5억 | 6.7% |
| 2026 1Q | 545억 | -4억 | 4억 | -0.7% |
Company
Address: 경기도 안산시 단원구 원시로 7
Peers in the same sector
Recent filings
- 2026-08-14반기보고서 (2026.06)
- 2026-05-15분기보고서 (2026.03)
- 2026-03-20사업보고서 (2025.12)
- 2026-02-26주요사항보고서(자기주식처분결정) Major
- 2025-12-02[기재정정]주요사항보고서(자기주식처분결정) Major
- 2025-12-02[기재정정]주요사항보고서(교환사채권발행결정) Major
- 2025-12-01[기재정정]주요사항보고서(자기주식처분결정) Major
- 2025-12-01[기재정정]주요사항보고서(교환사채권발행결정) Major
- 2025-11-25주요사항보고서(자기주식처분결정) Major
- 2025-11-25주요사항보고서(교환사채권발행결정) Major
Source: DART (Financial Supervisory Service electronic disclosure)
Recent news
- 2026-09-15신풍제약, SP-8203 3상 변경…혈전용해제 '메탈라제' 반영 [공시pick] 조세일보
- 2026-08-29삼성바이오·뷰노 유증에 주가 급락…신풍제약·조아제약↑[바이오 맥... 이데일리
- 2026-08-28코로나19 다시 확산?…신풍제약 주가 ‘불기둥’ [오늘, 이 종목] 매경이코노미
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.